STOCK TITAN

Evommune: Point72 reports 6.7% ownership stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Evommune, Inc. (EVMN) is the subject of an amended Schedule 13G reporting 2,434,080 common shares, or 6.7%, as beneficially owned by each of Point72 Asset Management, L.P., Point72 Capital Advisors, Inc., and Steven A. Cohen as of September 30, 2026. These reports describe the same fund-held position, not three separate holdings.

The shares are held by Point72 Associates, LLC, an investment fund managed by Point72 Asset Management. Each reporting person reports shared voting and dispositive power over the shares and no sole voting or dispositive power. The statement says its filing is not an admission that any reporting person is a beneficial owner for purposes of the Securities Exchange Act.

Beneficially owned common shares 2,434,080 shares Each of the three reporting persons reported this position as of September 30, 2026; the shares are held by Point72 Associates, LLC.
Percent of class 6.7% Reported by each reporting person as of September 30, 2026.
Shared voting power 2,434,080 shares Reported by each reporting person as of September 30, 2026.
Shared dispositive power 2,434,080 shares Reported by each reporting person as of September 30, 2026.
beneficial ownership regulatory
"amount beneficially owned by each reporting person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Shared Voting Power regulatory
"shared voting power over securities held by Point72 Associates"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"shared dispositive power over securities held by Point72 Associates"
investment management agreement technical
"under an investment management agreement, Point72 Asset Management maintains investment and voting power"
An investment management agreement is a written contract that hires a professional to make buying, selling and strategy decisions for an investment account or fund, and sets out their duties, fees, risk limits, performance measures and reporting requirements. It matters to investors because the agreement determines who controls the money, how much the service costs, what risks are allowed, and how success or failure is measured—think of it as the service contract that defines expectations and remedies for a hired portfolio manager.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many EVMN shares did Point72 report?

Point72 Asset Management, Point72 Capital Advisors, and Steven A. Cohen each reported beneficial ownership of 2,434,080 Evommune common shares, or 6.7%, as of September 30, 2026. The shares are held by investment fund Point72 Associates, LLC.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





30054Y107

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/16/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/16/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:11/16/2026

Keep reading